AFP and hepatocellular carcinoma: Serum alpha-fetoprotein (AFP) can also be considered a surrogate marker of HCC differentiation and vascular invasion [26], and the measurement of AFP serum levels before LT is a useful tool for identifying patients with a high risk of HCC recurrence [27], especially when associated with morphological criteria [28].